Crossmark

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development

Crossref DOI link: https://doi.org/10.1007/s10555-026-10322-5

Published Online: 2026-03-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van Galen, Joseph https://orcid.org/0000-0002-4400-528X
Willis, Stephen D. https://orcid.org/0000-0002-2083-7460
Bains, Ashish https://orcid.org/0000-0003-0421-8819
Small, Sara H. https://orcid.org/0000-0003-1246-0250
License Information

Text and Data Mining valid from 2026-03-27

Version of Record valid from 2026-03-27
More Information

Article History

Received: 3 December 2025

Accepted: 21 February 2026

First Online: 27 March 2026

Declarations

:

: The authors declare no competing interests.